A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection.

MLA

Pollin, Toni I., et al. “A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection.” Science, vol. 322, no. 5908, Dec. 2008, pp. 1702–05. EBSCOhost, https://doi.org/10.1126/science.1161524.

APA

Pollin, T. I., Damcott, C. M., Haiqing Shen, Ott, S. H., Shelton, J., Horenstein, R. B., Post, W., McLenithan, J. C., Bielak, L. F., Peyser, P. A., Mitchell, B. D., Miller, M., O’Connell, J. R., & Shuldiner, A. R. (2008). A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection. Science, 322(5908), 1702–1705. https://doi.org/10.1126/science.1161524

Chicago

Pollin, Toni I., Coleen M. Damcott, Haiqing Shen, Sandra H. Ott, John Shelton, Richard B. Horenstein, Wendy Post, et al. 2008. “A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection.” Science 322 (5908): 1702–5. doi:10.1126/science.1161524.